For the quarter ending 2026-03-31, RCEL made $19,251K in revenue. -$10,611K in net income. Net profit margin of -55.12%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Total revenues | 19,251 | 18,390* | 17,062 | 18,418 |
| Cost of sales | 3,523 | 2,810* | 3,187 | 3,469 |
| Gross profit | 15,728 | 15,580* | 13,875 | 14,949 |
| Sales and marketing | 12,841 | 13,586* | 12,053 | 14,314 |
| General and administrative | 6,061 | 6,534* | 7,227 | 6,666 |
| Research and development | 5,629 | 7,542* | 3,748 | 5,117 |
| Total operating expenses | 24,531 | 27,661* | 23,028 | 26,097 |
| Operating loss | -8,803 | -12,081* | -9,153 | -11,148 |
| Interest expense | 1,424 | 1,224* | 1,268 | 1,252 |
| Other expense, net | -395 | -637* | -2,751 | 2,484 |
| Loss before income taxes | -10,622 | -13,943* | -13,172 | -9,916 |
| Income tax benefit (expense) | -11 | -17* | 15 | 4 |
| Net loss | -10,611 | -13,926 | -13,187 | -9,920 |
| Basic EPS | -0.35 | -0.483 | -0.46 | -0.38 |
| Diluted EPS | -0.35 | -0.483 | -0.46 | -0.38 |
| Basic Average Shares | 30,540,872 | 28,821,359 | 28,393,445 | 26,367,548 |
| Diluted Average Shares | 30,540,872 | 28,821,359 | 28,393,445 | 26,367,548 |
AVITA Medical, Inc. (RCEL)
AVITA Medical, Inc. (RCEL)